Treatment-induced damage to the tumor microenvironment promotes prostate cancer therapy resistance through WNT16B
Impact in
- Oncology 254
Classified as
- Journal
- Nature Medicine
In The Last Decade
doi.org/10.1038/nm.2890 →Countries where authors are citing Treatment-induced damage to the tumor microenvironment promotes prostate cancer therapy resistance through WNT16B
This map shows the geographic impact of Treatment-induced damage to the tumor microenvironment promotes prostate cancer therapy resistance through WNT16B. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Treatment-induced damage to the tumor microenvironment promotes prostate cancer therapy resistance through WNT16B with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Treatment-induced damage to the tumor microenvironment promotes prostate cancer therapy resistance through WNT16B more than expected).
Fields of papers citing Treatment-induced damage to the tumor microenvironment promotes prostate cancer therapy resistance through WNT16B
This network shows the impact of Treatment-induced damage to the tumor microenvironment promotes prostate cancer therapy resistance through WNT16B. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the Treatment-induced damage to the tumor microenvironment promotes prostate cancer therapy resistance through WNT16B.
About Treatment-induced damage to the tumor microenvironment promotes prostate cancer therapy resistance through WNT16B
This paper, published in 2012, received 626 indexed citations . Written by Yu Sun, Judith Campisi, Celestia S. Higano, Tomasz M. Beer, Peggy L. Porter, Ilsa M. Coleman, Lawrence D. True and Peter S. Nelson covering the research area of Molecular Biology and Cancer Research. It is primarily cited by scholars working on Molecular Biology (291 citations), Oncology (254 citations), Cancer Research (144 citations), Immunology (125 citations) and Pulmonary and Respiratory Medicine (87 citations). Published in Nature Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
This paper is also available at doi.org/10.1038/nm.2890.